175 related articles for article (PubMed ID: 36193502)
1. HSPA5 Could Be a Prognostic Biomarker Correlated with Immune Infiltration in Breast Cancer.
Zhang C; Liu Q; Zhou Y; Hua J; Su R; Ai J
Dis Markers; 2022; 2022():7177192. PubMed ID: 36193502
[TBL] [Abstract][Full Text] [Related]
2. A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5.
Zhu RK; Zhang W; Zhang YX; Hui Z; Wang XW
Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37157205
[TBL] [Abstract][Full Text] [Related]
3. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
Dong W; Du D; Huang H
Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
[TBL] [Abstract][Full Text] [Related]
4. Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer.
Qi A; Ju M; Liu Y; Bi J; Wei Q; He M; Wei M; Zhao L
Pathol Oncol Res; 2021; 27():600727. PubMed ID: 34257557
[No Abstract] [Full Text] [Related]
5. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
7. A human pan-cancer system analysis of heat shock protein family A member 5.
Deng C; Gong S; Lin L; Tang J; Pang X; Wu P
Am J Cancer Res; 2023; 13(5):1698-1717. PubMed ID: 37293179
[TBL] [Abstract][Full Text] [Related]
8. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.
Gao T; Jiang B; Zhou Y; He R; Xie L; Li Y
Front Immunol; 2024; 15():1369892. PubMed ID: 38707897
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
11. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
12. Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis.
Ren H; Hu D; Mao Y; Su X
Med Sci Monit; 2020 Apr; 26():e920212. PubMed ID: 32251269
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical prognostic value of CYB561 in breast cancer.
Zhou X; Shen G; Ren D; Guo X; Han J; Guo Q; Zhao F; Wang M; Dong Q; Li Z; Zhao J
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1879-1892. PubMed ID: 35486183
[TBL] [Abstract][Full Text] [Related]
14. Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis.
Wu Z; Wan J; Wang J; Meng X; Qian H
Biochem Biophys Rep; 2022 Mar; 29():101203. PubMed ID: 35059509
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
[TBL] [Abstract][Full Text] [Related]
16. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
17. Multidimensional pan-cancer analysis of HSPA5 and its validation in the prognostic value of bladder cancer.
Wang Y; Wang J; Liu Y; Wang X; Ren M
Heliyon; 2024 Mar; 10(6):e27184. PubMed ID: 38496902
[TBL] [Abstract][Full Text] [Related]
18. CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer.
Tang S; Zhang Y; Lin X; Wang H; Yong L; Zhang H; Cai F
Oncol Lett; 2022 Aug; 24(2):285. PubMed ID: 35814828
[TBL] [Abstract][Full Text] [Related]
19. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
[TBL] [Abstract][Full Text] [Related]
20. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
Shen C; Liu J; Wang J; Yang X; Niu H; Wang Y
Dis Markers; 2020; 2020():4312629. PubMed ID: 32454905
[No Abstract] [Full Text] [Related]
[Next] [New Search]